Home |
About Us |
Investor Relations |
Products & Services |
Science & Technology |
People |
News & Events |
Contact Us
News |
Events
|
|
 |
|
||
 |
||
| |
|
 |
 |
|
16 January 2004 Cyprotex plc ("Cyprotex" or the "Company") Result of Extraordinary General Meeting ("EGM") and Placing of 30,000,000 New Ordinary Shares at 10p per share Board appointment Cyprotex is pleased to announce that following the announcement made on 23 December 2003 relating to the proposed placing of new shares, at the Extraordinary General Meeting held earlier today, all resolutions were duly passed by members of the Company. Application has been made for these Placing Shares to be admitted to the Alternative Investment Market ("AIM"). Admission of the placing Shares to AIM is expected to become effective at 8.00 am on 21 January 2004. Definitions used in the Circular apply in this announcement unless the context otherwise requires. The Company is also pleased to announce the appointment of Minhaz Manji as a non-executive director of the Company with immediate effect. Minhaz is the Managing Director of Monteacute House Limited, which builds limited service hotels under the name of Express by Holiday Inn (a franchise) of InterContinental Hotels Group. The company has a development agreement to build 15 hotels. Minhaz currently serves as the elected Chairman of Express Owners in the UK, currently numbering 80 hotels - an investment of over £600 million. He also serves as a director on the advisory board of the newly formed InterContinental Group and serves on the Ethnic Minority Advisory Board of HRH Prince Charles Youth Business Trust. Matters for disclosure under paragraph 15 of the AIM Rules with respect to the appointment of Minhaz Manji as a Director of Cyprotex plc: Full name: Minhaz Haiderali Manji Age: 42 Current directorships: Hospitality & Capital Management Limited Hospitality & Capital Management Cardiff Limited Hospitality & Capital Management Swindon Limited Rosemont Lodgings Limited Monteacute House Limited Directorships held within the last 5 years: As above There are no further disclosures required to be made pursuant to paragraph 15 of the AIM Rules for companies. For further information: Robert Atwater, Chairman and Chief Executive Cyprotex plc Tel: +44 (0) 1625 505100 rmatwater@cyprotex.com www.cyprotex.com Henry Harrison-Topham / Heather Salmond Bankside Consultants Limited Tel: +44 (0) 20 7444 4140 heather.salmond@bankside.com www.bankside.com |
|
|
 |
|
